Thompson Tamar sold (to issuer) $119K of CPRX
Thompson Tamar sold (to issuer) 3,773 shares of CATALYST PHARMACEUTICALS, INC. (CPRX) at $31.50 ($0.12M total) on 2026-07-15.
How this was made
The 30-second read
Why it matters
The newest disclosed fact is the director’s sale of 3,773 shares at $31.50/share, with holdings after the transaction reported as 0 shares.
Market read
Traders may note insider selling and the transaction price, but there is no accompanying fundamental catalyst in the text.
What to watch
No 10b5-1 plan is indicated, but the filing does not explain intent; without additional insider activity or fundamental news, signal quality is low.
Background
The filing is an SEC Form 4 insider transaction for Catalyst Pharmaceuticals, Inc. (CPRX).
Ticker impact
Catalyst Pharmaceuticals director Thompson Tamar sold 3,773 shares to the issuer on 2026-07-15 at $31.50/share, leaving 0 shares.
Likely limited near-term impact; any effect would be sentiment-only unless paired with other disclosures.
Form 4 provides a concrete transaction and price, but it does not include new company fundamentals, guidance, or regulatory/operational developments.
Market effects
Minimal; this is company-specific insider transaction data with no sector-wide catalyst.
None indicated.
None indicated.
Counterpoint
The sale is coded as “sale to issuer” and may reflect scheduled buyback participation or liquidity needs rather than bearish information.
Key entities
- issuerCATALYST PHARMACEUTICALS, INC.
CPRX, the company whose director insider transaction is disclosed.
- insiderThompson Tamar
Director who sold 3,773 shares to the issuer on 2026-07-15.